Prostate immunotherapy: should all guns be aimed at the prostate-specific antigen?

A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy

(2013) Tracy R Daniels-Wells et al.   BMC CANCER

DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8+ T-cell responses and increases PSA doubling time

(2012) Lindsey Chudley et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer

(2012) Nadeem A. Sheikh et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Immunology beats cancer: a blueprint for successful translation

(2012) Drew M Pardoll   NATURE IMMUNOLOGY

Cancer immunotherapy: a paradigm shift for prostate cancer treatment

(2012) Dev Karan et al.   Nature Reviews Urology

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice

(2011) Dev Karan et al.   Immunotherapy

One Man at a Time — Resolving the PSA Controversy

(2011) Mary F. McNaughton-Collins et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cellular Vaccine Approaches

(2010) Dung T. Le et al.   CANCER JOURNAL

Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

(2010) Philip W. Kantoff et al.   JOURNAL OF CLINICAL ONCOLOGY

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

(2010) Philip W. Kantoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase I Clinical Trial of an Adenovirus/Prostate-Specific Antigen Vaccine for Prostate Cancer: Safety and Immunologic Results

(2009) D. M. Lubaroff et al.   CLINICAL CANCER RESEARCH

Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients With Stage D0 Prostate Cancer

(2009) Douglas G. McNeel et al.   JOURNAL OF CLINICAL ONCOLOGY